Universal Health Services (UHS) Q2 Earnings: What To Expect
UHS
Hospital management company Universal Health ServicesUHSwill be announcing earnings results this Monday after the bell. Here’s what investors should know
Universal Health Services beat analysts’ revenue expectations last quarter, reporting revenues of $4.50 billion, up 9.6% year on year. It was a strong quarter for the company, with a beat of analysts’ EPS estimates
Is Universal Health Services a buy or sell going into earnings?Read our full analysis here, it’s free for active Edge members
This quarter, the market is expecting Universal Health Services’s revenue to grow 7.1% year on year, slowing from the 9.6% increase it recorded in the same quarter last year
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Universal Health Services has missed Wall Street’s revenue estimates multiple times over the last two years
Looking at Universal Health Services’s peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Tenet Healthcare delivered year-on-year revenue growth of 6.8%, beating analysts’ expectations by 3.9%, and HCA Healthcare reported revenues up 8.7%, topping estimates by 2.4%. Tenet Healthcare traded up 17.2% following the results
Read our full analysis ofTenet Healthcare’s results hereandHCA Healthcare’s results here
Investors in the healthcare providers & services segment have had steady hands going into earnings, with share prices up 1.2% on average over the last month. Universal Health Services is up 6.4% during the same time and is heading into earnings with an average analyst price target of $205.24 (compared to the current share price of $155.81)
WHILE YOU’RE HERE: The Next Palantir?One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this
Stock StoryUS stocks
Read more from Stock Story
